Fundraising Fox

Lifordi Immunotherapeutics

4 known investors

lifordi.com ↗

Lifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization. The company serves patients with immunological disorders and rare genetic conditions.

BiotechDeep TechHealthtech

Founders & leadership

AO
Arthur O. Tzianabos, Ph.D.President and CEO
NB
Naina Bhasin, Ph.D.Chief Business Officer

Investors · 4

ARCH Venture Partners✓ verifiedChicago
Atlas Venture✓ verifiedCambridge
Sanofi Ventures✓ verified
5AM Ventures✓ verifiedBoston

In the news